Center to Advance Research Excellence for Addiction Treatment at Stanford (OPTIC)
Official title: Center to Advance Research Excellence (OPTIC)
Funded at Rand Corporation · NIH-11394356 · Data updated 2026-11-12
A national-style center aims to speed up real-world use of proven addiction treatments so that people who need them can access care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project start | August 15, 2018 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $2,710,629 |
| NIH project number | 5P50DA046351-09 |
| Project ID | NIH-11394356 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with substance use disorders who could benefit from evidence-based treatments and services.
✕Less likely to help
People not seeking addiction treatment or in settings without implementation opportunities may see limited direct benefit.
What this research studies
This center consolidates addiction implementation researchers to improve how evidence-based treatments are adopted in practice. It focuses on standardized measures, cross-study data harmonization, and modeling to respond more effectively to substance-related health care gaps. The Administrative Core offers training and open online resources to build capacity in implementation research. The center emphasizes ethical, scalable strategies to spread proven interventions across diverse communities.
Why it matters
Potential benefit: If successful, patients could receive evidence-based addiction care more consistently and quickly.
How similar studies have gone: Prior implementation centers have shown improvements in adopting treatments, though the field continually seeks better standardization and scalability.
Where this research is happening
-
Rand Corporation
Santa Monica, United States Active
Researchers
- Principal investigator: Stein, Bradley D — Rand Corporation
- Study coordinator: Stein, Bradley D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.